Orthopedic Biologics Supplier Serving Roanoke, Virginia

Cold-chain receiving for Southeast practices

Cryopreserved Wharton's jelly products ship overnight on dry ice in validated containers and should go directly into -80 degree C storage on arrival. Orthopedic practices and surgery centers in Roanoke should designate a receiving contact and record arrival condition, including remaining dry ice, for each shipment.

Lyophilized formats are shelf-stable and do not require this handling, which can simplify stocking for a surgery center ordering a mix of product types.

• Assign a receiving contact for cold-chain deliveries
• Confirm available -80 degree C freezer space before the shipment arrives
• Log arrival time and dry ice remaining
• Record the lot identifier against internal inventory

NPI-verified accounts

Every order requires an NPI-verified account. Orthopedic groups with multiple surgeons across a shared practice or surgery center commonly register the account under the NPI of a supervising physician, with case coordinators or purchasing staff added as ordering contacts.

Once verified, an account does not need to resubmit credentials for future orders, and pricing is shared directly with verified accounts rather than published.

Documentation requested before purchase

Each lot carries a unique identifier, and a certificate of analysis, donor eligibility summary, and lot release record are available on request. Surgery centers often keep this documentation on file alongside their own tracking of product use by lot at the patient-record level.

Supplier-provided literature and characterization data for exosome products are also available to verified accounts for internal review.

Vendor qualification and account setup

Before adding a new supplier, orthopedic groups generally route the decision through a medical director and confirm regulatory posture with the Virginia Board of Medicine and their own counsel, particularly for exosome products, which FDA has stated have no currently approved versions. Precision Biologics does not make clinical recommendations.

Our team supports new Roanoke-area accounts through NPI verification, documentation requests, and first-shipment logistics.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.